FindTrial
Sign In

Predicting early post transplant sepsis and first 30 days mortality after LDLT using pre transplant Serum procalcitonin

"Pre transplant serum Procalcitonin as a predictor of post-transplant sepsis and first 30 days mortality after liver donor liver transplant- A prospective observational study".

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/03/032213
Enrollment
38
Registered
2021-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K746- Other and unspecified cirrhosis ofliver

Interventions

None listed

Sponsors

ILBS Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients (18-65 years) undergoing live donor liver transplant in Institute of Liver and Biliary Sciences

Exclusion criteria

Exclusion criteria: Paediatric patients ( Non consenting patient Acute liver failure

Design outcomes

Primary

MeasureTime frame
Correlation of pre transplant serum procalcitonin with development of early post transplant sepsis (within 7 days)Timepoint: 7 days—

Secondary

MeasureTime frame
Pretransplant and surgical risk factors associated with post transplant sepsis Correlation of pre transplant serum procalcitonin with first 30 days mortalityTimepoint: 30 days—

Countries

India

Contacts

Public ContactSonam Gupta

ILBS Hospital

lgmitra@hotmail.com8130657296

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026